Mahamaya Lifesciences Ltd
Mahamaya Lifesciences Ltd (MAHALIFE) last traded at ₹197, a market capitalisation of ₹461 crore, on a P/E of 27.9. Over the past 52 weeks the stock has ranged between ₹111 and ₹205. Mahamaya Lifesciences Ltd last reported results for the quarter ended Mar 2026, with sales of ₹166 crore and net profit of ₹8 crore. Mahamaya Lifesciences Ltd’s annual general meeting is scheduled for 29 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.
Mahamaya Lifesciences Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Mahamaya Lifesciences Ltd quarterly results
| ₹ crore | Sep 2024 | Sep 2025 | Mar 2026 |
|---|---|---|---|
| Sales | 146 | 163 | 166 |
| Expenses | 133 | 148 | 149 |
| Operating profit | 13 | 15 | 17 |
| OPM % | 9% | 9% | 10% |
| Other income | 1 | 1 | 1 |
| Interest | 4 | 4 | 4 |
| Depreciation | 1 | 1 | 1 |
| Profit before tax | 10 | 11 | 12 |
| Tax % | 27% | 27% | 35% |
| Net profit | 7 | 8 | 8 |
| EPS (₹) | 4.08 | 4.71 | 3.48 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Mahamaya Lifesciences Ltd annual results
| ₹ crore | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Sales | 90 | 137 | 161 | 264 | 329 |
| Operating profit | 6 | 9 | 13 | 23 | 34 |
| OPM % | 7% | 6% | 8% | 9% | 10% |
| Net profit | 3 | 4 | 5 | 13 | 17 |
| EPS (₹) | 21.78 | 30.03 | 41.80 | 7.28 | 7.06 |
TTM is the trailing twelve months to the most recent quarter.
Mahamaya Lifesciences Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 34%
- TTM
- 25%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 64%
- TTM
- 28%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- 1 Year
- %
- 10 Years
- %
- 5 Years
- 23%
- 3 Years
- 24%
- Last Year
- 19%
Mahamaya Lifesciences Ltd shareholding pattern
Promoters held 56.35% at Mar 2026, broadly unchanged since Nov 2025. FIIs 4.77% and DIIs 2.52%.
| % held | Nov 2025 | Mar 2026 |
|---|---|---|
| Promoters | 56.35% | 56.35% |
| FIIs | 6.39% | 4.77% |
| DIIs | 4.67% | 2.52% |
| Public | 32.60% | 36.35% |
| No. of shareholders | 1,034 | 584 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
When is Mahamaya Lifesciences Ltd’s AGM?
Mahamaya Lifesciences Ltd’s annual general meeting is scheduled for 29 Sept 2026.
- AGM24th Annual General Meeting
See the full results calendar for every Indian company reporting in the next 30 days.
Mahamaya Lifesciences Ltd corporate filings
- Appointment of Mr. Kush Mishra as Company Secretary and Compliance OfficerCompany Updatemedium impact
Cruxal's analysis: Mahamaya Lifesciences Limited has announced a significant leadership transition effective…
Read the full analysis - Investor Presentation to be shared during Investor Meet scheduled to be held on 07th August, 2026Company Updatelow impact
Cruxal's analysis: Mahamaya Lifesciences Limited has filed an intimation regarding an investor presentation…
Read the full analysis - Intimation of Schedule of Analyst(s) /Investor(s) meetingCompany Updatelow impact
Cruxal's analysis: Mahamaya Lifesciences Ltd. has announced the intimation of a schedule for an upcoming…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Mahamaya Lifesciences Ltd
Cruxal reads every Mahamaya Lifesciences Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.